You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 281 No. 12, March 24, 1999 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Medical News & Perspectives
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (25)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

AIDS Researchers Target Poor Adherence

Joan Stephenson, PhD

JAMA. 1999;281:1069.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

CHICAGO—Clinicians giving potent combinations of antiretroviral drugs to patients with HIV to suppress the virus are finding just how much the effectiveness of such regimens depends on strict adherence.

Although there are many potential reasons—such as individual differences in drug absorption or metabolism—for the failure of highly active antiretroviral therapy (HAART) to keep a patient's HIV in check, experts believe the chief reason is poor adherence to treatment regimens, which can promote the emergence of drug-resistant strains. New findings presented at the 6th Conference on Retroviruses and Opportunistic Infections last month in Chicago underscored the importance of strict adherence in maintaining "virologic success"—sustained suppression of HIV—and examined factors associated with poor adherence.


PILL-TAKING MONITORED

To get a snapshot of how well 84 HIV-infected patients at two sites were adhering to treatment with protease inhibitors, researchers from the VA Medical Center in Pittsburgh and the University of . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Directly Observed Therapy to Treat HIV Infection in Prisoners
Sergio Babudieri, Antonio Aceti, Gian Piero D'Offizi, Sergio Carbonara, and Giulio Starnini
JAMA. 2000;284(2):179-180.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Adherence to Medical Regimens: Understanding the Effects of Cognitive Appraisal, Quality of Life, and Perceived Family Resiliency
Frain et al.
Rehabil Couns Bull 2009;52:237-250.
ABSTRACT  

Directly Observed Therapy to Treat HIV Infection in Prisoners
Babudieri et al.
JAMA 2000;284:179-180.
FULL TEXT  

Oral Treatment with Trimethoprim-Sulfamethoxazole and Zidovudine Suppresses Murine Accessory Cell-Dependent Immune Responses
Freund et al.
Toxicol Sci 2000;55:335-342.
ABSTRACT | FULL TEXT  

Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: Effects on virologic, immunologic, and toxicity parameters
Dybul et al.
Proc. Natl. Acad. Sci. USA 2001;98:15161-15166.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.